Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Top 5 Singapore stocks to watch in November 2022

Analysts say these five Singapore stocks are among the ones to watch this month. Here are their insights.

singapore stocks shares price to buy trade best top dbs ocbc wilmar sia manulife Source: Bloomberg

DBS Group Holdings Ltd (SGX: D05)

Shares of Singapore’s most valuable company have gathered a consensus rating of ‘outperform’, alongside a price target of S$39.11 on the stock.

The price target equates to a 14.4% upside potential from DBS’ last traded price of S$34.20 on 3 November 2022.

UOB’s equity research team rated DBS shares a ‘buy’ on 25 October, while lifting their price target to S$45.75 from $43.60.

DBS’ third quarter (Q3) net profit rose 32% from the same quarter a year ago to a ‘record’ S$2.24 billion, surpassing UOB’s prediction of an 18% increase to S$2.01 billion.

Wilmar International Limited (SGX: F34)

The agricultural commodity group have seen its shares drop by 11% in the last six months, and by around 6% since the start of the year.

For now, analysts believe the large cap stock will continue to ‘outperform’ in the next 12 months, with a potential upside of 38% to the stock price.

The latest stock rating and share price target came from RHB’s equity research team. The analysts rated Wilmar a ‘buy’ alongside a higher price target of S$5.40, up from S$4.95 previously.

RHB wrote that Wilmer’s results for the first nine months of 2022 ‘surpassed expectations’, coming in at ‘102% to 104% of full-year forecasts’.

It believes that the stock ‘remains severely undervalued’, trading at 7.9 times its 2023 full-year price-to-earnings (P/E) ratio.

Oversea-Chinese Banking Corporation (SGX: O39)

OCBC's share price rose nearly 2% after the release of its latest quarterly results.

The group’s net profit rose 31% year-on-year from S$1.22 billion in Q3 2021 to S$1.6 billion during the same period this year.

This exceeded UOB analysts’ profit prediction of S$1.42 billion.

Group CEO Helen Wong said while ‘the global economic outlook is expected to be increasingly challenging’, the bank is ‘well-positioned’ to ‘capture opportunities as they arise’.

As of 7 November 2022, the stock has a consensus rating of ‘outperform’ and an average price target of S$14.08 a share. The price target would imply a 16.8% upside potential from OCBC’s last traded price of S$12.06.

OCBC shares are up 5.5% in 2022.

SIA Engineering Co Ltd (SGX: S59)

The latest analyst sentiments published by SGX StockFacts show a consensus rating of ‘outperform’, alongside a share price target of S$2.60 on SIA Engineering.

The price target equates to a 17.6% upside potential from the stock's last traded price of S$2.21.

CIMB analysts said the stock was worth adding in its latest investor note, raising the price target from S$2.42 to S$2.44.

The aviation engineering company has declined over 16% in the last six months.

SIA Engineering’s CFO said during its latest earnings call that the rising flight activity level this year has not translated into the same pace of recovery for maintenance, repair and overhaul (MRO) service providers.

Manulife US REIT (SGX: BTOU)

DBS, RHB and CIMB analysts recently lowered their price targets on Manulife US real estate investment trust (REIT), following the company’s latest quarterly update.

DBS cut its price target on Manulife US REIT shares to S$0.48 (from S$0.70), while both RHB and CIMB reduced their price targets to S$0.64 and S$0.69 respectively.

The REIT achieved a lower portfolio occupancy of 88.1% in Q3 2022, against 90% the previous quarter. It also said that headwinds from interest rate hikes will continue to impact the real estate sector in the following quarters.

Across the board, Manulife US REIT shares have a consensus rating of ‘outperform’ and an average price target of US$0.744 (S$1.06), based on the latest SGX StockFacts data on 3 November 2022.

The price target equates to a 110% upside potential from its last traded price of US$0.355 (S$0.51).

Keen to trade these Straits Times Index shares?

Go long or short via CFDs on Singapore shares with our award-winning platform.* Open an account with us to start trading shares immediately.

*Awarded the Best Online Trading Platform by Influential Brands in 2021.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.